CASP3 and Sepsis: In view of the possible deleterious effects of using caspase inhibitors to treat sepsis, therapy directed at a temporary inhibition of specific caspases, such as caspase-3 or capase-12, timed to either the hyperinflammatory phase or the hypoinflammatory phase of sepsis, might be the most effective approach.